{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 413"}, "official-title": {"#tail": "\n\t", "#text": "To eliminate the 2-year delay in including oral-only\n\t\t  ESRD-related drugs in the Medicare ESRD prospective payment system, as provided\n\t\t  under section 632(b)(1) of the American Taxpayer Relief Act of\n\t\t  2012."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130123", "#text": "January 23, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in\n\t\t\t addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the\n\t\t\t Speaker, in each case for consideration of such provisions as fall within the\n\t\t\t jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and\n\t\t\t Means"}], "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Welch", "@name-id": "W000800"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Hanna", "@name-id": "H001051"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Cooper", "@name-id": "C000754"}, {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Mr. Braley of Iowa", "@name-id": "B001259"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H9F3D6B1179F545E6812AB2338F2F257F", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": {"@section-type": "section-one", "#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "quote": {"#tail": " and inserting the\n\t\t\t following::", "#text": "With respect to the implementation"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking all that\n\t\t\t precedes ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 632(b) of the American Taxpayer\n\t\t\t Relief Act of 2012", "@value": "American Taxpayer Relief Act of 2012/s:632/ss:b"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public Law 112\u2013240", "@value": "public-law/112/240"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Eliminating the 2-year delay\n\t\t\t in implementation of oral-only ESRD-related drugs in the Medicare ESRD\n\t\t\t prospective payment system"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "subsection": {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "With respect to the\n\t\t\t\timplementation", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Monitoring of\n\t\t\t\timplementation of oral-Only ESRD-Related drugs in the ESRD prospective payment\n\t\t\t\tsystem"}, "#text": "\n          ", "@id": "H068E43C1D0C541BAA12BBB198AC5C31C"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HE0E15A7D6B7F4F8DB07645510F2A9A17"}, "#text": "\n      ", "@id": "HF86720E777AE46AE935853736162E738"}, "#text": "\n\t\t", "@id": "HCA8829018FEF43B8B32D5170DF6FAB93"}}}